Month: April 2024

Associate Director, Translational Development & Partnerships Serene leads strategic partnership initiatives at Histoindex by driving industry collaborations to incorporate HistoIndex’s technology in clinical trials and studies, across NASH and fibrotic diseases including oncology. Previously, Serene founded and led Clinnovate Health as CEO, a contract research and health innovation organization offering histopathology and genomic services with …

Serene Lek Read More »

Associate Director, Regulatory Affairs and Clinical Services Elaine oversees wide-ranging applications of Histoindex’s proprietary AI-based digital pathology platform in clinical trials and studies. She works closely with key opinion leaders to advance validation and adoption of the company’s innovative tissue analysis solutions to advocate for the company’s AI-powered platforms utilisation in FDA trials. Elaine holds …

Elaine Chng Read More »

Director, Clinical Development Yukti provides strategic oversight and leads implementation of HistoIndex’s proprietary platforms into clinical diagnostics and routine patient care. At HistoIndex, Yukti works closely with hospital labs to clinically validate and obtain reimbursement coverage for lab-developed tests developed on the company’s digital pathology platform. Previously, Yukti served as Chief Technology Officer and co-founder …

Yukti Choudhury Read More »

Chief Technology Officer (CTO) Teng Xiao received his Ph.D. in Computer Engineering from Nanyang Technological University, Singapore. Since joining HistoIndex in 2013, Teng Xiao has designed and developed core image processing and machine learning (ML) algorithms for the company’s proprietary software technology.

Chief Operating Officer (COO) Paddy brings over 20 years of industry and leadership experience to his role as Chief Operating Officer. At HistoIndex, he drove major change initiatives and programs focused on process improvement, organizational effectiveness, and client success. Paddy is an accomplished leader with diverse experience working across a range of industries for global …

Paddy Liang Read More »

Co-founder & Chief Scientific Officer (CSO) As the CSO of HistoIndex, Dean is responsible for the strategic product development and worldwide research collaboration. Together with his HistoIndex co-founder, Dr. Gideon Ho, Dean has successfully launched the company’s platform technology in multiple global clinical studies. He has established multi-centre clinical trials with key opinion leaders, and …

Dean Tai Read More »

Co-founder and CEO An A*STAR National Science Scholar (Fellowship), Gideon has been involved in bio-imaging research, commercial development and corporate management. In 2010, Gideon co-founded HistoIndex as a spin-off from the Agency for Science, Technology and Research (A*STAR), to develop and commercialise the world’s first fully automated, quantitative, stain-free imaging system and gain a first-mover …

Gideon Ho Read More »